HydroPeptide Lash Longer Fuller Lusher is rapidly gaining popularity in the US as the new lash product due to its drug-free formulation and impressive results. HydroPeptide Lash’s popularity is partly due to the fact that the product does not contain “glaucoma type meds” like Latisse®, Peter Thomas Roth Lashes To Die for, Lilash or MD Lash Factor. The FDA is taking action against the other products because the “use of Age Intervention Eyelash may cause other adverse effects in certain people due to the bimatoprost, including macular edema (swelling of the retina) and uveitis (inflammation in the eye), which may lead to decreased vision.”

STAAR Surgical Company has been given the green light from China’s State Food and Drug Administration (SFDA) to market its minimally invasive ICL (Implantable Collamer Lens) products. The Visian Toric ICL has been approved for treating nearsightedness and astigmatism, while the Visian Hyperopic ICL, or Visian ICH, has been approved for correcting hyperopia or farsightedness. Both these products offer a more aesthetically pleasing outcome than competing technology due to their unique foldable design, which allows the placement of the lens behind the iris.